Stocktoria
Lite Strategy, Inc. LITS
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2003-12-18
Lite Strategy, Inc. financials (annual)
Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0 | $65.3M | $48.8M | $40.7M | $34.8M | $27.8M | $4.9M | $1.6M | $23.2M |
| R&D expense | $122,000 | $3.9M | $16.6M | $52.5M | $85.6M | $69.4M | $34.1M | $32.3M | $17.0M | $7.2M |
| Operating income | -$66.6M | -$17.5M | $14.5M | -$36.8M | -$75.5M | -$60.4M | -$25.7M | -$46.2M | -$28.6M | $2.4M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $8,000 | $1,000 | $1,000 | $1,000 | $1,000 |
| Net income | -$71.2M | -$15.9M | $18.0M | -$32.0M | -$54.5M | -$41.3M | -$47.2M | -$16.8M | -$40.1M | $2.7M |
| EPS (diluted) | $-2.06 | $-2.39 | $2.67 | $-4.78 | $-9.99 | $-0.60 | $-0.52 | $-0.75 | $-0.97 | $0.07 |
| Operating cash flow | -$9.1M | -$20.8M | -$50.5M | -$52.5M | -$48.7M | -$32.0M | $34.3M | -$29.4M | -$21.0M | $3.5M |
| Free cash flow | — | -$20.8M | -$50.5M | -$52.5M | -$49.2M | -$32.7M | $33.4M | -$29.6M | — | $3.4M |
| Cash & equivalents | $5.7M | $18.0M | $3.7M | $16.9M | $15.7M | $8.5M | $12.3M | $9.6M | $13.3M | $8.5M |
| Total assets | $42.7M | $18.3M | $41.4M | $120.8M | $177.8M | $174.1M | $209.7M | $82.7M | $104.7M | $55.7M |
| Total liabilities | $1.1M | $1.4M | $8.4M | $96.2M | $125.4M | $124.6M | $131.5M | $34.7M | $54.2M | $4.9M |
| Shareholders' equity | $41.6M | $16.9M | $33.0M | $24.6M | $52.4M | $49.5M | $77.1M | $47.9M | $50.5M | $50.8M |
Growth · year-over-year
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | -100.0% | +33.8% | +19.9% | +17.0% | +25.4% | +464.7% | +203.0% | -93.0% | — |
| Net income growth | — | -188.6% | — | — | — | — | — | — | -1600.7% | — |
| EPS growth | — | -189.5% | — | — | — | — | — | — | -1485.7% | — |
| Free cash flow growth | — | — | — | — | — | -197.9% | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2026-06-30. Facts plus Stocktoria's own computed scores — not investment advice.